29 results on '"Rosner, Bernard"'
Search Results
2. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.
- Author
-
Wolfson, Emily A, Schonberg, Mara A, Eliassen, A Heather, Bertrand, Kimberly A, Shvetsov, Yurii B, Rosner, Bernard A, Palmer, Julie R, LaCroix, Andrea Z, Chlebowski, Rowan T, Nelson, Rebecca A, and Ngo, Long H
- Subjects
BREAST cancer ,CANCER patients ,BREAST imaging ,ONCOLOGY nursing ,DISEASE risk factors ,SURVIVAL analysis (Biometry) ,WOMEN'S health - Abstract
Background To support mammography screening decision making, we developed a competing-risk model to estimate 5-year breast cancer risk and 10-year nonbreast cancer death for women aged 55 years and older using Nurses' Health Study data and examined model performance in the Black Women's Health Study (BWHS). Here, we examine model performance in predicting 10-year outcomes in the BWHS, Women's Health Initiative-Extension Study (WHI-ES), and Multiethnic Cohort (MEC) and compare model performance to existing breast cancer prediction models. Methods We used competing-risk regression and Royston and Altman methods for validating survival models to calculate our model's calibration and discrimination (C index) in BWHS (n = 17 380), WHI-ES (n = 106 894), and MEC (n = 49 668). The Nurses' Health Study development cohort (n = 48 102) regression coefficients were applied to the validation cohorts. We compared our model's performance with breast cancer risk assessment tool (Gail) and International Breast Cancer Intervention Study (IBIS) models by computing breast cancer risk estimates and C statistics. Results When predicting 10-year breast cancer risk, our model's C index was 0.569 in BWHS, 0.572 in WHI-ES, and 0.576 in MEC. The Gail model's C statistic was 0.554 in BWHS, 0.564 in WHI-ES, and 0.551 in MEC; IBIS's C statistic was 0.547 in BWHS, 0.552 in WHI-ES, and 0.562 in MEC. The Gail model underpredicted breast cancer risk in WHI-ES; IBIS underpredicted breast cancer risk in WHI-ES and in MEC but overpredicted breast cancer risk in BWHS. Our model calibrated well. Our model's C index for predicting 10-year nonbreast cancer death was 0.760 in WHI-ES and 0.763 in MEC. Conclusions Our competing-risk model performs as well as existing breast cancer prediction models in diverse cohorts and predicts nonbreast cancer death. We are developing a website to disseminate our model. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Risk prediction models for endometrial cancer: development and validation in an international consortium
- Author
-
Shi, Joy, primary, Kraft, Peter, additional, Rosner, Bernard, additional, Benavente, Yolanda, additional, Black, Amanda, additional, Brinton, Louise A, additional, Chen, Chu, additional, Clarke, Megan A, additional, Cook, Linda S, additional, Costas, Laura, additional, Dal Maso, Luigino, additional, Freudenheim, Jo L, additional, Frias-Gomez, Jon, additional, Friedenreich, Christine M, additional, Garcia-Closas, Montserrat, additional, Goodman, Marc T, additional, Johnson, Lisa, additional, La Vecchia, Carlo, additional, Levi, Fabio, additional, Lissowska, Jolanta, additional, Lu, Lingeng, additional, McCann, Susan E, additional, Moysich, Kirsten B, additional, Negri, Eva, additional, O'Connell, Kelli, additional, Parazzini, Fabio, additional, Petruzella, Stacey, additional, Polesel, Jerry, additional, Ponte, Jeanette, additional, Rebbeck, Timothy R, additional, Reynolds, Peggy, additional, Ricceri, Fulvio, additional, Risch, Harvey, additional, Sacerdote, Carlotta, additional, Setiawan, Veronica W, additional, Shu, Xiao-Ou, additional, Spurdle, Amanda B, additional, Trabert, Britton, additional, Webb, Penelope M, additional, Wentzensen, Nicolas, additional, Wilkens, Lynne R, additional, Xu, Wang Hong, additional, Yang, Hannah P, additional, Yu, Herbert, additional, Du, Mengmeng, additional, and De Vivo, Immaculata, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status
- Author
-
Houghton, Serena C, primary, Eliassen, Heather, additional, Tamimi, Rulla M, additional, Willett, Walter C, additional, Rosner, Bernard A, additional, and Hankinson, Susan E, additional
- Published
- 2020
- Full Text
- View/download PDF
5. Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status.
- Author
-
Houghton, Serena C, Eliassen, Heather, Tamimi, Rulla M, Willett, Walter C, Rosner, Bernard A, and Hankinson, Susan E
- Subjects
DISEASE risk factors ,HOT flashes ,BREAST cancer ,PROPORTIONAL hazards models ,OBESITY ,WAIST-hip ratio ,PERIMENOPAUSE ,RESEARCH ,RESEARCH methodology ,EVALUATION research ,COMPARATIVE studies ,WAIST circumference ,RESEARCH funding ,BODY mass index ,BREAST tumors ,ADIPOSE tissues ,LONGITUDINAL method - Abstract
Background: Increased body mass index (BMI) is associated with higher postmenopausal breast cancer risk and lower premenopausal breast cancer risk. Less is known about the central adiposity-breast cancer risk association, particularly for tumor subtypes.Methods: We used prospective waist (WC) and hip circumference (HC) measures in the Nurses' Health Studies. We examined associations of WC, HC, and waist-to-hip ratio (WHR) with breast cancer independent of BMI, by menopausal status. Cox proportional hazards models estimated the hazard ratios (HRs) and 95% confidence intervals (CIs) adjusting for breast cancer risk factors, with and without BMI.Results: Adjusting for BMI, WC and HC were not associated, and WHR was positively associated with premenopausal breast cancer risk (WHR, quintile 5 vs 1: HRQ5vQ1, BMI-adjusted = 1.27, 95% CI = 1.04 to 1.54; Ptrend = .01), particularly for estrogen receptor-negative (ER-) and progesterone receptor-negative (PR-) and basal-like breast cancers. Premenopausal WC, HC, and WHR were not associated with postmenopausal breast cancer risk, with or without BMI adjustment. Postmenopausal WC, HC, and WHR were each positively associated with postmenopausal breast cancer (eg, WC HRQ5vsQ1 = 1.59, 95% CI = 1.36 to 1.86); after adjustment for BMI, only WC remained statistically significant (HRQ5vsQ1, BMI-adjusted = 1.38, 95% CI = 1.15 to 1.64; Ptrend = .002). In postmenopausal women, associations were stronger among never-users of hormone therapy and for ER+/PR+ breast cancers.Conclusions: Central adiposity was positively associated with pre- and postmenopausal breast cancers independent of BMI. This suggests that mechanisms other than estrogen may also play a role in the relationship between central adiposity and breast cancer. Maintaining a healthy waist circumference may decrease pre- and postmenopausal breast cancer risk. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
6. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses’ Health Studies
- Author
-
Kensler, Kevin H, primary, Poole, Elizabeth M, additional, Heng, Yujing J, additional, Collins, Laura C, additional, Glass, Benjamin, additional, Beck, Andrew H, additional, Hazra, Aditi, additional, Rosner, Bernard A, additional, Eliassen, A Heather, additional, Hankinson, Susan E, additional, Winer, Eric P, additional, Brown, Myles, additional, and Tamimi, Rulla M, additional
- Published
- 2018
- Full Text
- View/download PDF
7. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
- Author
-
Kensler, Kevin H, Poole, Elizabeth M, Heng, Yujing J, Collins, Laura C, Glass, Benjamin, Beck, Andrew H, Hazra, Aditi, Rosner, Bernard A, Eliassen, A Heather, Hankinson, Susan E, Winer, Eric P, Brown, Myles, and Tamimi, Rulla M
- Subjects
ANDROGEN receptors ,BREAST cancer ,PROPORTIONAL hazards models ,HORMONE receptors ,CANCER-related mortality - Abstract
Background: Hormone receptor signaling is critical in the progression of breast cancers, although the role of the androgen receptor (AR) remains unclear, particularly for estrogen receptor (ER)-negative tumors. This study assessed AR protein expression as a prognostic marker for breast cancer mortality.Methods: This study included 4147 pre- and postmenopausal women with invasive breast cancer from the Nurses' Health Study (diagnosed 1976-2008) and Nurses' Health Study II (1989-2008) cohorts. AR protein expression was evaluated by immunohistochemistry and scored through pathologist review and as a digitally quantified continuous measure. Hazard ratios (HR) and 95% confidence intervals (CI) of breast cancer mortality were estimated from Cox proportional hazards models, adjusting for patient, tumor, and treatment covariates.Results: Over a median 16.5 years of follow-up, there were 806 deaths due to breast cancer. In the 7 years following diagnosis, AR expression was associated with a 27% reduction in breast cancer mortality overall (multivariable HR = 0.73, 95% CI = 0.58 to 0.91) a 47% reduction for ER+ cancers (HR = 0.53, 95% CI = 0.41 to 0.69), and a 62% increase for ER- cancers (HR = 1.62, 95% CI = 1.18 to 2.22) (P heterogeneity < .001). A log-linear association was observed between AR expression and breast cancer mortality among ER- cancers (HR = 1.14, 95% CI = 1.02 to 1.26 per each 10% increase in AR), although no log-linear association was observed among ER+ cancers.Conclusions: AR expression was associated with improved prognosis in ER+ tumors and worse prognosis in ER- tumors in the first 5-10 years postdiagnosis. These findings support the continued evaluation of AR-targeted therapies for AR+/ER- breast cancers. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
8. Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival
- Author
-
Cao, Yin, primary, Lindström, Sara, additional, Schumacher, Fredrick, additional, Stevens, Victoria L., additional, Albanes, Demetrius, additional, Berndt, Sonja I., additional, Boeing, Heiner, additional, Bas Bueno-de-Mesquita, H., additional, Canzian, Federico, additional, Chamosa, Saioa, additional, Chanock, Stephen J., additional, Diver, W. Ryan, additional, Gapstur, Susan M., additional, Gaziano, J. Michael, additional, Giovannucci, Edward L., additional, Haiman, Christopher A., additional, Henderson, Brian, additional, Johansson, Mattias, additional, Marchand, Loïc Le, additional, Palli, Domenico, additional, Rosner, Bernard, additional, Siddiq, Afshan, additional, Stampfer, Meir, additional, Stram, Daniel O., additional, Tamimi, Rulla, additional, Travis, Ruth C., additional, Trichopoulos, Dimitrios, additional, Willett, Walter C., additional, Yeager, Meredith, additional, Kraft, Peter, additional, Hsing, Ann W., additional, Pollak, Michael, additional, Lin, Xihong, additional, and Ma, Jing, additional
- Published
- 2014
- Full Text
- View/download PDF
9. Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis
- Author
-
Pettersson, Andreas, primary, Graff, Rebecca E., additional, Ursin, Giske, additional, dos Santos Silva, Isabel, additional, McCormack, Valerie, additional, Baglietto, Laura, additional, Vachon, Celine, additional, Bakker, Marije F., additional, Giles, Graham G., additional, Chia, Kee Seng, additional, Czene, Kamila, additional, Eriksson, Louise, additional, Hall, Per, additional, Hartman, Mikael, additional, Warren, Ruth M. L., additional, Hislop, Greg, additional, Chiarelli, Anna M., additional, Hopper, John L., additional, Krishnan, Kavitha, additional, Li, Jingmei, additional, Li, Qing, additional, Pagano, Ian, additional, Rosner, Bernard A., additional, Wong, Chia Siong, additional, Scott, Christopher, additional, Stone, Jennifer, additional, Maskarinec, Gertraud, additional, Boyd, Norman F., additional, van Gils, Carla H., additional, and Tamimi, Rulla M., additional
- Published
- 2014
- Full Text
- View/download PDF
10. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
- Author
-
Schonberg, Mara A., Li, Vicky W., Eliassen, A. Heather, Davis, Roger B., LaCroix, Andrea Z., McCarthy, Ellen P., Rosner, Bernard A., Chlebowski, Rowan T., Rohan, Thomas E., Hankinson, Susan E., Marcantonio, Edward R., and Ngo, Long H.
- Abstract
Background: The Breast Cancer Risk Assessment Tool (BCRAT, "Gail model") is commonly used for breast cancer prediction; however, it has not been validated for women age 75 years and older.Methods: We used Nurses' Health Study (NHS) data beginning in 2004 and Women's Health Initiative (WHI) data beginning in 2005 to compare BCRAT's performance among women age 75 years and older with that in women age 55 to 74 years in predicting five-year breast cancer incidence. BCRAT risk factors include: age, race/ethnicity, age at menarche, age at first birth, family history, history of benign breast biopsy, and atypia. We examined BCRAT's calibration by age by comparing expected/observed (E/O) ratios of breast cancer incidence. We examined discrimination by computing c-statistics for the model by age. All statistical tests were two-sided.Results: Seventy-three thousand seventy-two NHS and 97 081 WHI women participated. NHS participants were more likely to be non-Hispanic white (96.2% vs 84.7% in WHI, P < .001) and were less likely to develop breast cancer (1.8% vs 2.0%, P = .02). E/O ratios by age in NHS were 1.16 (95% confidence interval [CI] = 1.09 to 1.23, age 57-74 years) and 1.31 (95% CI = 1.18 to 1.45, age ≥ 75 years, P = .02), and in WHI 1.03 (95% CI = 0.97 to 1.09, age 55-74 years) and 1.10 (95% CI = 1.00 to 1.21, age ≥ 75 years, P = .21). E/O ratio 95% confidence intervals crossed one among women age 75 years and older when samples were limited to women who underwent mammography and were without significant illness. C-statistics ranged between 0.56 and 0.58 in both cohorts regardless of age.Conclusions: BCRAT accurately predicted breast cancer for women age 75 years and older who underwent mammography and were without significant illness but had modest discrimination. Models that consider individual competing risks of non-breast cancer death may improve breast cancer risk prediction for older women. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
11. Unmetabolized Folic Acid in Prediagnostic Plasma and the Risk of Colorectal Cancer.
- Author
-
Eunyoung Cho, Xuehong Zhang, Townsend, Mary K., Selhub, Jacob, Paul, Ligi, Rosner, Bernard, Fuchs, Charles S., Willett, Walter C., Giovannucci, Edward L., Cho, Eunyoung, and Zhang, Xuehong
- Subjects
ENRICHED foods ,COLON tumors ,DIETARY supplements ,FOLIC acid ,HETEROCYCLIC compounds ,OXIDOREDUCTASES ,RECTUM tumors ,RISK assessment ,SEX distribution ,CASE-control method ,GENOTYPES ,DIAGNOSIS - Abstract
Higher folate has been associated with a reduced colorectal cancer (CRC) risk, but excessive folate may promote tumor progression. The role of unmetabolized folic acid (UFA) from high folic acid consumption in carcinogenesis is largely unexplored. We evaluated prediagnostic plasma levels of UFA in relation to CRC risk in nested case-control studies (618 CRC case patients and 1207 matched control) with blood samples collected prior to folic acid fortification. UFA was detected in 21.4% of control UFA levels were not associated with CRC risk. Compared with undetectable levels, the multivariable relative risks (RRs) of CRC were 1.03 (95% confidence interval [CI] = 0.73 to 1.46) for less than 0.5 nmol/L and 1.12 (95% CI = 0.81 to 1.55) for 0.5 nmol/L or more (Ptrend = .32). A positive association between UFA levels and CRC risk was observed among men (RR = 1.57, 95% CI = 0.99 to 2.49 for ≥0.5 nmol/L vs undetectable, Pinteraction = .04), and a positive association was also observed among those with the methylene-tetrahydrofolate reductase (MTHFR) CT/TT genotype (RR = 2.20, 95% CI = 1.22 to 3.94 for ≥0.5 nmol/L vs undetectable, Pinteraction=0.02). In conclusion, prediagnostic plasma levels of UFA from the prefortification period were not associated with risk of CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. Predictive Value Tools as an Aid in Chemopreventive Agent Development.
- Author
-
Eunyoung Cho, Xuehong Zhang, Townsend, Mary K., Selhub, Jacob, Paul, Ligi, Rosner, Bernard, Fuchs, Charles S., Willett, Walter C., Giovannucci, Edward L., Dunn, Barbara K, Steele, Vernon E, Fagerstrom, Richard M, Topp, Carol F, Ransohoff, David, Cunningham, Christopher, Lubet, Ron, Ford, Leslie G, and Kramer, Barnett S
- Subjects
BREAST tumor prevention ,TUMOR prevention ,COLON tumor prevention ,ANIMALS ,ANTINEOPLASTIC agents ,BREAST tumors ,CELL lines ,CHEMOPREVENTION ,COLON tumors ,MICE ,PREVENTIVE health services ,RATS ,TUMORS ,TREATMENT effectiveness ,PREDICTIVE tests ,STATISTICAL models ,PHARMACODYNAMICS - Abstract
Background: Over 25 years, the National Cancer Institute's Division of Cancer Prevention has entered some 800 agents into a chemopreventive agent testing program. Two critical steps involve: 1) in vitro/in vivo morphologic assays and 2) animal tumor assays (incidence/multiplicity reduction). We sought to determine how accurately the earlier-stage (morphologic) assays predict efficacy in the later-stage (animal tumor) assays.Methods: Focusing on 210 agents tested in both morphologic and animal tumor assays, we carried out statistical modeling of how well the six most commonly used morphologic assays predicted drug efficacy in animal tumor assays. Using multimodel inference, three statistical models were generated to evaluate the ability of these six morphologic assays to predict tumor outcomes in three different sets of animal tumor assays: 1) all tumor types, 2) mammary cancer only, and 3) colon cancer only. Using this statistical modeling approach, each morphologic assay was assigned a value reflecting how strongly it predicted outcomes in each of the three different sets of animal tumor assays.Results: We demonstrated differences in the predictive value of specific morphologic assays for positive animal tumor assay results. Some of the morphologic assays were strongly predictive of meaningful positive efficacy outcomes in animal tumor assays representing specific cancer types, particularly the aberrant crypt focus (ACF) assay for colon cancer. Moreover, less strongly predictive assays can be combined and sequenced, resulting in enhanced composite predictive ability.Conclusions: Predictive models such as these could be used to guide selection of preventive agents as well as morphologic and animal tumor assays, thereby improving the efficiency of our approach to chemopreventive agent development. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
13. Dietary Lycopene, Angiogenesis, and Prostate Cancer: A Prospective Study in the Prostate-Specific Antigen Era.
- Author
-
Ke Zu, Mucci, Lorelei, Rosner, Bernard A., Clinton, Steven K., Loda, Massimo, Stampfer, Meir J., and Giovannucci, Edward
- Subjects
LYCOPENE ,CANCER prevention ,PROSTATE cancer ,PROSTATE-specific antigen ,NEOVASCULARIZATION ,NUTRITION - Abstract
Background The role of lycopene in prostate cancer prevention remains controversial. We examined the associations between dietary lycopene intake and prostate cancer, paying particular attention to the influence of prostate-specific antigen screening, and evaluated tissue biomarkers in prostate cancers in relation to lycopene intake. Methods Among 49898 male health professionals, we obtained dietary information through questionnaires and ascertained total and lethal prostate cancer cases from 1986 through January 31, 2010. Cox regression was used to estimate multivariable hazard ratios (HRs) and 95% confidence intervals (CIs). Tissue microarrays and immuno-histochemistry were used to assess tumor biomarker expression in a subset of men. Two-sided χ² tests were used to calculate the P values. Results Higher lycopene intake was inversely associated with total prostate cancer and more strongly with lethal prostate cancer (top vs bottom quintile: HR = 0.72; 95% CI = 0.56 to 0.94; P
trend = .04). In a restricted population of screened participants, the inverse associations became markedly stronger (for lethal prostate cancer: HR = 0.47; 95% CI = 0.29 to 0.75; Ptrend = .009). Comparing different measures of dietary lycopene, early intake, but not recent intake, was inversely associated with prostate cancer. Higher lycopene intake was associated with biomarkers in the cancer indicative of less angiogenic potential. Conclusions Dietary intake of lycopene was associated with reduced risk of lethal prostate cancer and with a lesser degree of angiogenesis in the tumor. Because angiogenesis is a strong progression factor, an endpoint of lethal prostate cancer may be more relevant than an endpoint of indolent prostate cancer for lycopene in the era of highly prevalent prostate-specific antigen screening. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
14. Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk.
- Author
-
Liu, Ying, Colditz, Graham A., Rosner, Bernard, Berkey, Catherine S., Collins, Laura C., Schnitt, Stuart J., Connolly, James L., Chen, Wendy Y., Willett, Walter C., and Tamimi, Rulla M.
- Subjects
ALCOHOLISM ,BREAST cancer research ,CANCER risk factors research ,BREAST diseases ,CANCER in women - Abstract
Background Adult alcohol consumption during the previous year is related to breast cancer risk. Breast tissue is particularly susceptible to carcinogens between menarche and first full-term pregnancy. No study has characterized the contribution of alcohol consumption during this interval to risks of proliferative benign breast disease (BBD) and breast cancer. Methods We used data from 91005 parous women in the Nurses’ Health Study II who had no cancer history, completed questions on early alcohol consumption in 1989, and were followed through June 30, 2009, to analyze breast cancer risk. A subset of 60093 women who had no history of BBD or cancer in 1991 and were followed through June 30, 2001, were included in the analysis of proliferative BBD. Relative risks (RRs) were estimated using Cox proportional hazard regression. Results We identified 1609 breast cancer cases and 970 proliferative BBD cases confirmed by central histology review. Alcohol consumption between menarche and first pregnancy, adjusted for drinking after first pregnancy, was associated with risks of breast cancer (RR = 1.11 per 10g/day intake; 95% confidence interval [CI] = 1.00 to 1.23) and proliferative BBD (RR = 1.16 per 10g/day intake; 95% CI = 1.02 to 1.32). Drinking after first pregnancy had a similar risk for breast cancer (RR = 1.09 per 10g/day intake; 95% CI = 0.96 to 1.23) but not for BBD. The association between drinking before first pregnancy and breast neoplasia appeared to be stronger with longer menarche to first pregnancy intervals. Conclusions Alcohol consumption before first pregnancy was consistently associated with increased risks of proliferative BBD and breast cancer. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
15. Nurses' Health Study: Log-Incidence Mathematical Model of Breast Cancer Incidence
- Author
-
Rosner, Bernard, primary and Colditz, Graham A., additional
- Published
- 1996
- Full Text
- View/download PDF
16. Risk Factors for Breast Cancer According to Family History of Breast Cancer
- Author
-
Colditz, Graham A., primary, Rosner, Bernard A., additional, and Speizer, Frank E., additional
- Published
- 1996
- Full Text
- View/download PDF
17. Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics.
- Author
-
Yaghjyan, Lusine, Colditz, Graham A., Collins, Laura C., Schnitt, Stuart J., Rosner, Bernard, Vachon, Celine, and Tamimi, Rulla M.
- Subjects
MAMMOGRAMS ,BREAST exams ,BREAST cancer ,CANCER risk factors ,POSTMENOPAUSE ,CANCER in women ,AMERICAN women - Abstract
Background Few studies that investigated the associations between breast density and subsequent breast cancer according to tumor characteristics have produced inconclusive findings. We aimed to determine whether the associations between breast density and subsequent breast cancer varied by tumor characteristics. Methods We included 1042 postmenopausal women diagnosed with breast cancer between June 1, 1989, and June 30, 2004, and 1794 matched control subjects from the Nurses’ Health Study, an ongoing prospective cohort study of 121 701 registered female nurses across the United States. Breast density was estimated from digitized images using computerized techniques. Information on breast cancer risk factors was obtained prospectively from biennial questionnaires before the date of cancer diagnosis for case subjects and matched control subjects. Polychotomous logistic regression was used to assess associations of breast density with tumor subtypes based on invasiveness, histology, size, grade, receptor status, and involvement of lymph nodes. All tests of statistical significance were two-sided. Results The risk of breast cancer increased progressively with increase in percent breast density (Ptrend < .001). Women with higher breast density (≥50%) showed a 3.39-fold (odds ratio = 3.39, 95% confidence interval = 2.46 to 4.68) increased risk of breast cancer compared with women with lower breast density (<10%). The associations between breast density and breast cancer risk were stronger for in situ compared with invasive tumors (Pheterogeneity < .01), high-grade compared with low-grade tumors (Pheterogeneity = .02), larger (>2 cm) compared with smaller (≤2 cm) tumors (Pheterogeneity < .01), and estrogen receptor–negative compared with estrogen receptor–positive tumors (Pheterogeneity = .04). There were no differences in associations by tumor histology, involvement of lymph nodes, and progesterone receptor and HER2 status (Pheterogeneity > .05). Conclusions The findings suggest that higher mammographic density is associated with more aggressive tumor characteristics and also with in situ tumors. [ABSTRACT FROM PUBLISHER]
- Published
- 2011
- Full Text
- View/download PDF
18. Effects of Reproductive and Demographic Changes on Breast Cancer Incidence in China: A Modeling Analysis.
- Author
-
Linos, Eleni, Spanos, Demetri, Rosner, Bernard A., Linos, Katerina, Hesketh, Therese, Qu, Jian Ding, Gao, Yu-Tang, Wei Zheng, and Colditz, Graham A.
- Subjects
BREAST cancer risk factors ,DISEASE incidence ,DEMOGRAPHIC change ,HEALTH risk assessment ,BREAST cancer patients ,LIFESTYLES ,HEALTH surveys ,PSYCHOLOGY - Abstract
Background Breast cancer incidence is currently low in China. However, the distribution of reproductive and lifestyle risk factors for breast cancer among Chinese women is changing rapidly. We quantified the expected effect of changes in breast cancer risk factors on future rates of breast cancer in China. Methods We first validated and calibrated the Rosner-Colditz log-incidence breast cancer model in Chinese women who participated in the Shanghai Women's Health Study cohort (N = 74942). We then applied the calibrated model to a representative sample of Chinese women who were aged 35-49 years in 2001 using data from the Chinese National Family Planning and Reproductive Health Survey (NFPRHS, N = 17078) to predict the age-specific and cumulative breast cancer incidence among all Chinese women of this age group. We evaluated the relative impact of changes in modifiable risk factors, including alcohol intake, parity, postmenopausal hormone use, and adult weight gain, on cumulative incidence of breast cancer. Results Breast cancer incidence in China is expected to increase substantially from current rates, estimated at 10-60 cases per 100000 women, to more than 100 new cases per 100000 women aged 55-69 years by 2021. We predicted 2.5 million cases of breast cancer by 2021 among Chinese women who were 35-49 years old in 2001. Modest reductions in hormone and alcohol use, and weight maintenance could prevent 270000 of these cases. Conclusions China is on the cusp of a breast cancer epidemic. Although some risk factors associated with economic development are largely unavoidable, the substantial predicted increase in new cases of breast cancer calls for urgent incorporation of this disease in future health care infrastructure planning. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
19. A Prospective Study of Age-Specific Physical Activity and Premenopausal Breast Cancer.
- Author
-
Maruti, Sonia S., Willett, Walter C., Feskanich, Diane, Rosner, Bernard, and Colditz, Graham A.
- Subjects
BREAST cancer risk factors ,MENOPAUSE -- Risk factors ,MENOPAUSE ,ACTIVITIES of daily living ,REGRESSION analysis ,STATISTICAL hypothesis testing - Abstract
Background Physical activity has been consistently associated with lower risk of postmenopausal breast cancer, but its relationship with premenopausal breast cancer is unclear. We investigated whether physical activity is associated with reduced incidence of premenopausal breast cancer, and, if so, what age period and intensity of activity are critical. Methods A total of 64 777 premenopausal women in the Nurses' Health Study II reported, starting on the 1997 questionnaire, their leisure-time physical activity from age 12 to current age. Cox regression models were used to examine the relationship between physical activity, categorized by age period (adolescence, adulthood, and lifetime) and intensity (strenuous, moderate, walking, and total), and risk of invasive premenopausal breast cancer. Results During 6 years of follow-up, 550 premenopausal women developed breast cancer. The strongest associations were for total leisure-time activity during participants' lifetimes rather than for any one intensity or age period. Active women engaging in 39 or more metabolic equivalent hours per week (MET-h/wk) of total activity on average during their lifetime had a 23% lower risk of premenopausal breast cancer (relative risk = 0.77; 95% confidence interval = 0.64 to 0.93) than women reporting less activity. This level of total activity is equivalent to 3.25 h/wk of running or 13 h/wk of walking. The age-adjusted incidence rates of breast cancer for the highest (≥54 MET-h/wk) and lowest (<21 MET-h/wk) total lifetime physical activity categories were 136 and 194 per 100 000 person-years, respectively. High levels of physical activity during ages 12-22 years contributed most strongly to the association. Conclusions Leisure-time physical activity was associated with a reduced risk for premenopausal breast cancer in this cohort. Premenopausal women regularly engaging in high amounts of physical activity during both adolescence and adulthood may derive the most benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
20. Fruit and Vegetable Intake and Risk of Major Chronic Disease.
- Author
-
Hsin-Chia Hung, Joshipura, Kaumudi J., Rui Jiang, Hu, Frank B., Hunter, David, Smith-Warner, Stephanie A., Colditz, Graham A., Rosner, Bernard, Spiegelman, Donna, and Willett, Walter C.
- Subjects
HEALTH ,INGESTION ,FRUIT ,VEGETABLES ,CARDIOVASCULAR diseases ,CANCER in women ,DISEASES in women ,CANCER ,DISEASE risk factors - Abstract
Background: Studies of fruit and vegetable consumption in relation to overall health are limited. We evaluated the relationship between fruit and vegetable intake and the incidence of cardiovascular disease and cancer and of deaths from other causes in two prospective cohorts. Methods: A total of 71 910 female participants in the Nurses' Health study and 37 725 male participants in the Health Professionals' Follow-up Study who were free of major chronic disease completed baseline semiquantitative food-frequency questionnaires in 1984 and 1986, respectively. Dietary information was updated in 1986, 1990, and 1994 for women and in 1990 and 1994 for men. Participants were followed up for incidence of cardiovascular disease, cancer, or death through May 1998 (women) and January 1998 (men). Multivariable-adjusted relative risks were calculated with Cox proportional hazards analysis. Results: We ascertained 9329 events (1964 cardiovascular, 6584 cancer, and 781 other deaths) in women and 4957 events (1670 cardiovascular diseases, 2500 cancers, and 787 other deaths) in men during follow-up. For men and women combined, participants in the highest quintile of total fruit and vegetable intake had a relative risk for major chronic disease of 0.95 (95% confidence interval [CI] = 0.89 to 1.01) times that of those in the lowest. Total fruit and vegetable intake was inversely associated with risk of cardiovascular disease but not with overall cancer incidence, with relative risk for an increment of five servings daily of 0.88 (95% CI = 0.81 to 0.95) for cardiovascular disease and 1.00 (95% CI = 0.95 to 1.05) for cancer. Of the food groups analyzed, green leafy vegetable intake showed the strongest inverse association with major chronic disease and cardiovascular disease. For an increment of one serving per day of green leafy vegetables, relative risks were 0.95 (95% CI = 0.92 to 0.99) for major chronic disease and 0.89 (95 % CI = 0.83 to 0.96) for cardiovascular disease. Conclusions: Increased fruit and vegetable consumption was associated with a modest although not statistically significant reduction in the development of major chronic disease. The benefits appeared to be primarily for cardiovascular disease and not for cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
21. Lung Cancer Rates in Men and Women With Comparable Histories of Smoking.
- Author
-
Bain, Chris, Feskanich, Diane, Speizer, Frank E., Thun, Michael, Hertzmark, Ellen, Rosner, Bernard A., and Colditz, Graham A.
- Subjects
SMOKING ,LUNG cancer ,SEX factors in disease ,DISEASE risk factors ,PREVENTIVE medicine ,CANCER prevention - Abstract
Background: Recent case-control studies suggest that, given equal smoking exposure, women may have a higher relative risk of developing lung cancer than men. Despite prospective data that conflict with this hypothesis, mechanistic studies to find a biologic basis for a sex difference continue. Methods: We addressed the hypothesis directly by analyzing prospective data from former and current smokers in two large cohorts—the Nurses' Health Study of women and the Health Professionals Follow-up Study of men. We calculated incidence rates and hazard ratios of lung cancer in women compared with men, adjusting for age, number of cigarettes smoked per day, age at start of smoking, and time since quitting, using Cox proportional hazards models. We also reviewed published results from prospective analyses. Results: From 1986 through 2000, 955 and 311 primary lung cancers were identified among 60 296 women and 25 397 men, respectively, who ranged in age from 40 to 79 years. Incidence rates per 100 000 person-years for women and men were 253 and 232, respectively, among current smokers and 81 and 73, respectively, among former smokers. The hazard ratio in women ever smokers compared with men was 1.11 (95% confidence interval = 0.95 to 1.31). Six published prospective cohort studies allowed assessment of comparative susceptibility to lung cancer by sex. None supported an excess risk of lung cancer for women. Conclusions: Women do not appear to have a greater susceptibility to lung cancer than men, given equal smoking exposure. Research should be focused on enhancing preventive interventions for all. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
22. Risk Factors for Breast Cancer According to Estrogen and Progesterone Receptor Status.
- Author
-
Colditz, Graham A., Rosner, Bernard A., Chen, Wendy Y., Holmes, Michelle D., and Hankinson, Susan E.
- Subjects
- *
BREAST cancer , *ESTROGEN receptors , *PROGESTERONE receptors , *LOGISTIC regression analysis , *WOMEN'S health , *MENOPAUSE - Abstract
Background: Evaluations of epidemiologic risk factors in relation to breast cancer classified jointly by estrogen receptor (ER) and progesterone receptor (PR) status have been inconsistent. To address this issue, we conducted a prospective evaluation of risk factors for breast cancer classified according to receptor status. Methods: During 1 029 414 person-years of follow-up of 66 145 women participating in the Nurses' Health Study from 1980 through 2000, we identified 2096 incident cases of breast cancer for which information on ER/PR status was available: 1281 were ER+/ PR+, 318 were ER+/PR-, 80 were ER-/PR+, and 417 were ER-/PR-. We fit a log-incidence model of breast cancer and used polychotomous logistic regression to compare coefficients for breast cancer risk factors in patients with different ER/PR status. To test for differences in risk factor odds ratios based on marginal ER/PR categories, we evaluated ER status controlling for PR status and vice versa. The predictive ability of our log-incidence model to discriminate between women who would develop ER+/PR+ breast cancer and those who would not (and similarly for ER-/ PR-breast cancer) was evaluated by using receiver operator characteristic curve analysis. All statistical tests were two-sided. Results: We observed statistically significant heterogeneity among the four ER/PR categories for some risk factors (age, menopausal status, body mass index [BMI] after menopause, the one-time adverse effect of first pregnancy, and past use of postmenopausal hormones) but not for others (benign breast disease, family history of breast cancer, alcohol use, and height). The one-time adverse association of first pregnancy with incidence was present for PR- but not for PR+ tumors after controlling for ER status (P = .007). However, the association of BMI after menopause with incidence was present for PR+ but not PR-tumors (P = .005). Statistically significant differences in the incidence of ER+ and ER-tumors were seen with age, both before and after menopause (P = .003), and with past use of postmenopausal hormones (P = .01). Area under the receiver operator characteristic curve, adjusted for age, was 0.64 (95% confidence interval [CI] = 0.63 to 0.66) for ER+/PR+ tumors and 0.61 (95% CI = 0.58 to 0.64) for ER-/PR-tumors. Conclusions: Incidence rates and risk factors for breast cancer differ according to ER and PR status. Thus, to accurately estimate breast cancer risk, breast cancer cases should be divided according to the ER and PR status of the tumor. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
23. Prospective Study of Recreational Physical Activity and Ovarian Cancer.
- Author
-
Bertone, Elizabeth R., Willet, Walter C., Rosner, Bernard A., Hunter, David J., Fuchs, Charles S., Speizer, Frank E., Colditz, Graham A., and Hankinson, Susan E.
- Subjects
EXERCISE ,OVARIAN cancer - Abstract
Reports the association of vigorous exercise and ovarian cancer. Relative risk of ovarian cancer; Effect of delaying the onset of menarche; Consequence of premenopausal physical activity.
- Published
- 2001
- Full Text
- View/download PDF
24. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
- Author
-
Hankinson, Susan E., Willett, Walter C., Michaud, Dominique S., Manson, JoAnn E., Colditz, Graham A., Longcope, Christopher, Rosner, Bernard, Speizer, Frank E., Hankinson, S E, Willett, W C, Michaud, D S, Manson, J E, Colditz, G A, Longcope, C, Rosner, B, and Speizer, F E
- Subjects
BREAST cancer risk factors ,MENOPAUSE ,BLOOD plasma - Abstract
Background: In animal studies, prolactin has been found to be important for mammary epithelial development and its administration has been shown consistently to increase the rate of mammary tumor formation. Previous epidemiologic studies of prolactin and breast cancer risk in postmenopausal women have been limited in size, and the results have been inconsistent. We conducted a nested case-control study within the prospective Nurses' Health Study cohort to better determine the relationship between plasma prolactin levels and postmenopausal breast cancer risk.Methods: Blood samples were collected from cohort members during the period from 1989 through 1990. Prolactin levels were measured by use of a microparticle enzyme immunoassay. Included in this analysis were 306 postmenopausal women who were diagnosed with breast cancer after blood donation but before June 1994. One or two postmenopausal control subjects were matched per case subject on the basis of age, postmenopausal hormone use, and time of day and month of blood collection; the study included a total of 448 control subjects.Results: In conditional logistic regression analyses, a significant positive association was observed between plasma level of prolactin and postmenopausal breast cancer risk (highest versus lowest quartile, multivariate relative risk = 2.03; 95% confidence interval = 1.24-3.31; two-sided P for trend = .01). The relationship was independent of plasma sex steroid hormone levels and was similar after excluding case subjects diagnosed in the first 2 years after blood collection.Conclusions: These prospective data suggest that higher plasma prolactin levels are associated with an increased risk of breast cancer in postmenopausal women. [ABSTRACT FROM AUTHOR]- Published
- 1999
- Full Text
- View/download PDF
25. Dietary Carotenoids and Vitamins A, C, and E and Risk of Breast Cancer.
- Author
-
Zhang, Shumin, Hunter, David J., Forman, Michele R., Rosner, Bernard A., Speizer, Frank E., Colditz, Graham A., Manson, JoAnn E., Hankinson, Susan E., and Willett, Walter C.
- Subjects
BREAST cancer risk factors ,VITAMINS in human nutrition - Abstract
Provides a study that examines the risk of breast cancer among premenopausal and postmenopausal women by dietary intakes of specific carotenoids and vitamins A, C, and E. Research methodology; What can increase risk of breast cancer; Other substances that can protect against cancer.
- Published
- 1999
- Full Text
- View/download PDF
26. Folate, methionine, and alcohol intake and risk of colorectal adenoma.
- Author
-
Giovannucci, Edward, Stampfer, Meir J., Colditz, Graham A., Rimm, Eric B., Trichopoulos, Dimitrios, Rosner, Bernard A., Speizer, Frank E., Willett, Walter C., Giovannucci, E, Stampfer, M J, Colditz, G A, Rimm, E B, Trichopoulos, D, Rosner, B A, Speizer, F E, and Willett, W C
- Abstract
Background: Reduced methylation of DNA may contribute to loss of the normal controls on proto-oncogene expression. In humans, hypomethylation of DNA has been observed in colorectal cancers and in their adenomatous polyp precursors. Accumulation of DNA methylation abnormalities, observed during progression of human colorectal neoplasia, may be influenced by certain dietary factors. The apparent protective effect of fresh fruits and vegetables, the major folate sources, on colorectal cancer incidence suggests that a methyl-deficient diet contributes to occurrence of this malignancy. Low dietary folate and methionine and high intake of alcohol may reduce levels of S-adenosylmethionine, which is required for DNA methylation.Purpose: To determine if dietary factors that may influence methyl availability are related to colorectal adenomas, we prospectively examined the association of folate, methionine, and alcohol intakes and risk of colorectal adenoma.Methods: We assessed dietary intake for a 1-year period for women of the Nurses' Health Study, started in 1976, and for men of the Health Professionals Follow-up Study, started in 1986--using a semiquantitative food frequency questionnaire. Adenomatous polyps of the left colon or rectum were diagnosed in 564 of 15,984 women who had had an endoscopy between 1980 and 1990 and in 331 of 9490 men who had undergone an endoscopy between 1986 and 1990.Results: High dietary folate was inversely associated with risk of colorectal adenoma in women (multivariate relative risk [RR] = 0.66; 95% confidence interval [CI] = 0.46-0.95 between high and low quintiles of intake) and in men (RR = 0.63; 95% CI = 0.41-0.98) after adjusting for age, family history, indications for endoscopy, history of previous endoscopy, total energy intake, saturated fat intake, dietary fiber, and body mass index. Relative to nondrinkers, drinkers of more than 30 g of alcohol daily (about two drinks) had an elevated risk of adenoma (in women, RR = 1.84, 95% CI = 1.19-2.86; in men, RR = 1.64, 95% CI = 0.92-2.93). Methionine intake was inversely associated with risk of adenomas 1 cm or larger (RR = 0.62; 95% CI = 0.46-0.85, combining men and women).Conclusions: Folate, alcohol, and methionine could influence methyl group availability, and a methyl-deficient diet may be linked to early stages of colorectal neoplasia. A dietary pattern that increases methyl availability could reduce incidence of colorectal cancer.Implications: These data support efforts to increase dietary folate in segments of the population having diets with low intakes of this nutrient. [ABSTRACT FROM AUTHOR]- Published
- 1993
27. Prospective Study of Smoking and the Risk of Breast Cancer.
- Author
-
London, Stephanie J., Colditz, Graham A., Stampfer, Meir J., Willett, Walter C., Rosner, Bernard A., and Speizer, Frank E.
- Abstract
In 1976, 117, 557 women in the United States aged 30–55 years and without a history of cancer provided detailed information on current smoking habits. By 1986, 1,788 cases of breast cancer had been documented during 1,133,682 person-years. There was no association between current smoking and risk of breast cancer (multivariate-adjusted relative risk for smokers of ≥25 cigarettes/day compared to nonsmokers: 1.02, 95% confidence interval, 0.86–1.22). Past smoking also was unrelated to breast cancer risk (relative risk, 1.08; 95% confidence interval, 0.96–1.20). The results did not differ by menopausal status. Tumor size and the presence of nodal metastases were unrelated to smoking. Smoking was weakly associated with estrogen receptor-positive tumors (relative risk for smokers of ≥25 cigarettes/day compared with never smokers, 1.38; 95% confidence interval, 1.04–1.84), but there was no dose-response relationship across categories of current smoking. These results suggest that smoking and breast cancer are not materially related [J Natl Cancer Inst 81:1625–1631, 1989] [ABSTRACT FROM PUBLISHER]
- Published
- 1989
28. Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer in Women.
- Author
-
Romieu, Isabelle, Willett, Walter C., Colditz, Graham A., Stampfer, Meir J., Rosner, Bernard, Hennekens, Charles H., and Speizer, Frank E.
- Abstract
In 1976, 118,273 female nurses 30–55 years of age with no history of cancer completed a questionnaire regarding possible risk factors. By 1986, after 1,137,415 person-years of follow-up, we had documented 1,799 newly diagnosed cases of breast cancer. Compared with the risk of breast cancer for nonusers of oral contraceptives, the multivariate relative risks were 1.07 (95% confidence interval, 0.97–1.19) for all users, 1.06 (95% confidence interval, 0.96–1.18) for past users, and 1.53 (95% confidence interval, 1.06–2.19) for current users—women who used oral contraceptives up to 2 years before diagnosis of breast cancer. We conclude that overall past use of oral contraceptives is not associated with a substantial increase in the risk of breast cancer. Although we did not find women who used oral contraceptives before the first pregnancy to have an increased risk of breast cancer, the number of women who used oral contraceptives for a long duration in early reproductive life was too small to permit firm conclusions regarding the risk in this subgroup. [J Natl Cancer Inst 81:1313–1321, 1989] [ABSTRACT FROM PUBLISHER]
- Published
- 1989
- Full Text
- View/download PDF
29. A Case-Control Study of Oral Contraceptive Use and Breast Cancer23
- Author
-
Hennekens, Charles H., primary, Speizer, Frank E., additional, Lipnick, Robert J., additional, Rosner, Bernard, additional, Bain, Christopher, additional, Belanger, Charlene, additional, Stampfer, Meir J., additional, Willett, Walter, additional, and Peto, Richard, additional
- Published
- 1984
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.